Skip to main content
. 2017 Jun 17;15:138. doi: 10.1186/s12967-017-1241-5

Fig. 4.

Fig. 4

Kaplan–Meier survival curves for non-small cell lung cancer (NSCLC) patients with lymph node metastasis. a Patients with high SCP3 expression (median survival, 16 months) showed significantly worse survival than those with low SCP3 expression (median survival, 66 months). b No significance in survival differences was observed for patients with expression of different VEGFs